Dashboard
Manage Tickers

COGT


   

CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

stifel-initiates-coverage-on-cogent-biosciences-with-hold-rating-announces-price-target-of-16
Stifel Initiates Coverage On Cogent Biosci...
10/16/2025 13:41:14

Stifel analyst Laura Prendergast initiates coverage on Cogent Biosciences (NASDAQ:COGT) with a Hold rating and announces Pri...

raymond-james-initiates-coverage-on-cogent-biosciences-with-strong-buy-rating-announces-price-target-of-30
Raymond James Initiates Coverage On Cogent...
09/03/2025 16:46:55

Raymond James analyst Chris Raymond initiates coverage on Cogent Biosciences (NASDAQ:COGT) with a Strong Buy rating and anno...

macys-increases-fy2025-outlook-joins-rev-group-healthequity-alphabet-and-wellness-and-other-big-stocks-moving-higher-on-wednesday
Macy's Increases FY2025 Outlook, Joins REV...
09/03/2025 14:10:50

guggenheim-maintains-buy-on-cogent-biosciences-raises-price-target-to-20
Guggenheim Maintains Buy on Cogent Bioscie...
08/25/2025 12:21:28

Guggenheim analyst Charles Zhou maintains Cogent Biosciences (NASDAQ:COGT) with a Buy and raises the price target from $17 t...

jp-morgan-maintains-overweight-on-cogent-biosciences-raises-price-target-to-30
JP Morgan Maintains Overweight on Cogent B...
08/07/2025 19:10:38

JP Morgan analyst Anupam Rama maintains Cogent Biosciences (NASDAQ:COGT) with a Overweight and raises the price target from ...

hc-wainwright--co-maintains-buy-on-cogent-biosciences-lowers-price-target-to-21
HC Wainwright & Co. Maintains Buy on Cogen...
08/06/2025 12:08:24

HC Wainwright & Co. analyst Robert Burns maintains Cogent Biosciences (NASDAQ:COGT) with a Buy and lowers the price targ...

cogent-biosciences-q2-eps-053-beats-058-estimate
Cogent Biosciences Q2 EPS $(0.53) Beats $(...
08/05/2025 21:45:16

Cogent Biosciences (NASDAQ:COGT) reported quarterly losses of $(0.53) per share which beat the analyst consensus estimate of $(...

cogent-biosciences-cash-position-as-of-june-30-2378m
Cogent Biosciences Cash Position As Of Jun...
08/05/2025 12:21:55

3-stocks-with-sky-high-overbought-signals-quantumscape-opendoor-cogent-flash-rsi-red-flags
3 Stocks With Sky-High Overbought Signals:...
07/21/2025 11:57:42

According to the technical analysis of over 4,400 firms with a market cap exceeding $100 million, three firms are in the overbo...

citigroup-maintains-buy-on-cogent-biosciences-raises-price-target-to-22
Citigroup Maintains Buy on Cogent Bioscien...
07/18/2025 16:35:39

Citigroup analyst David Lebowitz maintains Cogent Biosciences (NASDAQ:COGT) with a Buy and raises the price target from $15 ...

jp-morgan-maintains-overweight-on-cogent-biosciences-raises-price-target-to-29
JP Morgan Maintains Overweight on Cogent B...
07/10/2025 18:45:57

JP Morgan analyst Anupam Rama maintains Cogent Biosciences (NASDAQ:COGT) with a Overweight and raises the price target from ...

reported-earlier-cogent-biosciences-prices-upsized-200m-public-offering-of-22222223-common-shares-at-9-each-to-advance-bezuclastinib-development-and-commercial-preparation
Reported Earlier, Cogent Biosciences Price...
07/09/2025 06:14:58

cogent-biosciences-announces-proposed-150m-public-offering-of-common-stock
Cogent Biosciences Announces Proposed $150...
07/08/2025 20:27:57

Cogent Biosciences, Inc. (NASDAQ: COGT), a biotechnology company focused on developing precision therapies for genetically defi...

cogents-chronic-immune-disorder-drug-has-strong-potential-to-become-a-blockbuster-analyst
Cogent's Chronic Immune Disorder Drug Has ...
07/08/2025 18:26:44

Cogent's bezuclastinib showed strong efficacy in a non-advanced SM trial, with a planned FDA submission expected by the end...

hc-wainwright--co-maintains-buy-on-cogent-biosciences-raises-price-target-to-22
HC Wainwright & Co. Maintains Buy on Cogen...
07/08/2025 14:54:09

HC Wainwright & Co. analyst Robert Burns maintains Cogent Biosciences (NASDAQ:COGT) with a Buy and raises the price targ...

guggenheim-reiterates-buy-on-cogent-biosciences-maintains-17-price-target
Guggenheim Reiterates Buy on Cogent Biosci...
07/08/2025 13:56:21

Guggenheim analyst Michael Schmidt reiterates Cogent Biosciences (NASDAQ:COGT) with a Buy and maintains $17 price target.

baird-maintains-neutral-on-cogent-biosciences-raises-price-target-to-9
Baird Maintains Neutral on Cogent Bioscien...
07/08/2025 13:12:41

Baird analyst Joel Beatty maintains Cogent Biosciences (NASDAQ:COGT) with a Neutral and raises the price target from $7 to $9.

us-stocks-likely-to-open-mixed-as-trump-issues-tariff-letters-experts-peg-ai-investments-as-durable-drivers-of-returns
US Stocks Likely To Open Mixed As Trump Is...
07/08/2025 10:24:03

U.S. stock futures were fluctuating on Tuesday after trimming gains on Monday. Futures of major benchmark indices were trading ...

trump-tariffs-sink-dow-over-400-points-investor-sentiment-declines-but-fear--greed-index-remains-in-extreme-greed-zone
Trump Tariffs Sink Dow Over 400 Points: In...
07/08/2025 06:37:32

jefferies-maintains-buy-on-cogent-biosciences-raises-price-target-to-28
Jefferies Maintains Buy on Cogent Bioscien...
07/07/2025 17:44:34

Jefferies analyst Kelly Shi maintains Cogent Biosciences (NASDAQ:COGT) with a Buy and raises the price target from $23 to $28.

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION